Life Molecular Imaging invests in clinical development of new tracers and new indications

ADvance Study:
PI-2620 Phase 3 on detection of TAU in patients with Alzheimer┬┤s disease

CArdiag Study:
[18F]florbetaben Phase 3 on diagnosis of cardiac AL amyloidosis

Life Molecular Imaging invests in clinical development of new tracers and new indications

ADvance Study:
PI-2620 Phase 3 on detection of TAU in patients with Alzheimer┬┤s disease

CArdiag Study:
[18F]florbetaben Phase 3 on diagnosis of cardiac AL amyloidosis